158 related articles for article (PubMed ID: 36918772)
1. Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Xu N; Yu Y; Duan C; Wei J; Sun W; Jiang C; Jian B; Cao W; Jia L; Ma X
Clin Proteomics; 2023 Mar; 20(1):10. PubMed ID: 36918772
[TBL] [Abstract][Full Text] [Related]
2. Urinary protein biomarkers for pediatric medulloblastoma.
Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
4. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling.
Rammal G; Fahs A; Kobeissy F; Mechref Y; Zhao J; Zhu R; Diab-Assaf M; Saab R; Ghayad SE
J Proteome Res; 2019 Oct; 18(10):3567-3579. PubMed ID: 31448612
[TBL] [Abstract][Full Text] [Related]
5. CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis.
Li Q; Zhang L; Jiang J; Zhang Y; Wang X; Zhang Q; Wang Y; Liu C; Li F
BMC Med Genomics; 2019 Dec; 12(1):198. PubMed ID: 31870357
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
9. Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.
McKinnon T; Venier R; Yohe M; Sindiri S; Gryder BE; Shern JF; Kabaroff L; Dickson B; Schleicher K; Chouinard-Pelletier G; Menezes S; Gupta A; Zhang X; Guha R; Ferrer M; Thomas CJ; Wei Y; Davani D; Guidos CJ; Khan J; Gladdy RA
Oncogene; 2018 May; 37(20):2630-2644. PubMed ID: 29487419
[TBL] [Abstract][Full Text] [Related]
10. MYL2 as a potential predictive biomarker for rhabdomyosarcoma.
Wang J; Gao S; Dong K; Guo P; Shan MJ
Medicine (Baltimore); 2021 Oct; 100(39):e27101. PubMed ID: 34596111
[TBL] [Abstract][Full Text] [Related]
11. Fisher discriminant model based on LASSO logistic regression for computed tomography imaging diagnosis of pelvic rhabdomyosarcoma in children.
Tian L; Li X; Zheng H; Wang L; Qin Y; Cai J
Sci Rep; 2022 Sep; 12(1):15631. PubMed ID: 36115914
[TBL] [Abstract][Full Text] [Related]
12. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry.
Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S
J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013
[No Abstract] [Full Text] [Related]
13. Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics.
Wu J; Zhang J; Wei J; Zhao Y; Gao Y
Chin Neurosurg J; 2020; 6():11. PubMed ID: 32922940
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyosarcoma in Karachi 1998-2002.
Bhurgri Y; Bhurgri A; Puri R; Ashraf S; Qidwai A; Ashraf K; Ahmed N; Mazhar A; Bhurgri H; Usman A; Faridi N; Malik J; Ahmed R; Muzaffar S; Kayani N; Pervez S; Hasan SH
Asian Pac J Cancer Prev; 2004; 5(3):284-90. PubMed ID: 15373708
[TBL] [Abstract][Full Text] [Related]
15. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries.
Schaaf GJ; Ruijter JM; van Ruissen F; Zwijnenburg DA; Waaijer R; Valentijn LJ; Benit-Deekman J; van Kampen AH; Baas F; Kool M
FASEB J; 2005 Mar; 19(3):404-6. PubMed ID: 15629888
[TBL] [Abstract][Full Text] [Related]
16. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
17. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
18. [Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].
Treuner J; Kaatsch P; Anger Y; Seipp A; Spaar HJ; Gerein V; Suder J; Niethammer D
Klin Padiatr; 1986; 198(3):208-17. PubMed ID: 3523026
[TBL] [Abstract][Full Text] [Related]
19. Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma.
Liu W; Wang Q; Chang J; Bhetuwal A; Bhattarai N; Zhang F; Tang J
Clin Proteomics; 2022 May; 19(1):18. PubMed ID: 35610567
[TBL] [Abstract][Full Text] [Related]
20. Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.
Liu C; Li D; Jiang J; Hu J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
PLoS One; 2014; 9(4):e94924. PubMed ID: 24743780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
